Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aussie Oncologists Say Trial Trend Makes Treatments Costlier

This article was originally published in PharmAsia News

Executive Summary

Australian oncologists are calling for independent research of cancer drugs to guard against overuse of expensive ones and those more toxic. The physicians wrote in a professional journal that clinical trials have shifted to testing how long drugs could be tolerated and away from using them until maximum response is determined and then halting their use to avoid toxicity. Their article in The Medical Journal of Australia said that shift toward longer use is not supported by survival or quality-of-life data, making treatment potentially much costlier. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts